Vote Scores

Home / Companies / NewAmsterdam Pharma Company N.V. / 2 Jun 2026

Meeting · year to 30 June 2026268 filers reporting

NewAmsterdam Pharma Company N.V.: meeting of 2 Jun 2026

Votes reported on Form N-PX, item by item

268 Form N-PX filers reported votes at the NewAmsterdam Pharma Company N.V. meeting of 2 Jun 2026. Their records fall into 7 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

2 nominees; 80.6% of reported votes for; 36 filers withheld from or voted against at least one nominee.

275 vote records from 94 filers. 1 of the 92 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.

61.7% for0.0% against38.3% other1.1% against management94 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

374 vote records from 266 filers. 57 of the 248 filers that marked the item either way voted against management. 18 filers reported this item without a management mark.

70.3% for22.2% against7.5% other23.0% against management266 filers94.5% for5.2% against0.2% other5.3% against management113,786,719 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

262 vote records from 94 filers. 1 of the 92 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.

96.8% for0.0% against3.2% other1.1% against management94 filers99.9% for0.0% against0.1% other0.1% against management48,589,617 reported shares
4

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

275 vote records from 93 filers. 64 of the 91 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.

22.6% for68.8% against8.6% other70.3% against management93 filers33.1% for66.9% against66.9% against management50,403,245 reported shares, counted once per item in this group
5

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

134 vote records from 88 filers. 2 of the 86 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.

95.5% for2.3% against2.3% other2.3% against management88 filers99.9% for0.1% against0.1% against management24,278,251 reported shares, counted once per item in this group
6

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

262 vote records from 93 filers. 1 of the 91 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.

96.8% for0.0% against3.2% other1.1% against management93 filers99.9% for0.0% against0.1% other0.1% against management49,381,735 reported shares, counted once per item in this group
7

OTHERIssuer

OTHER: management items

Management items in this category are shown together; filers word and number them differently.

17 vote records from 9 filers. 0 of the 9 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management9 filers100.0% for0.0% against0.0% against management1,282,180 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForForFor
State Street and SPDRSplit or no voteForFor
American CenturySplit or no voteAgainst *For
Franklin TempletonForForFor
InvescoForAgainst *For
EquitableForForFor
Charles SchwabNo reportForNo report
Nuveen and TIAANo reportForNo report
ProShares and ProFundsSplit or no voteForFor
John Hancock and ManulifeNo reportForNo report
Morgan Stanley, Eaton Vance and CalvertForForFor
J.P. MorganForForFor
Goldman SachsForForFor
PGIM and PrudentialForAgainst *For
Northern Trust and FlexSharesNo reportForNo report
SEINo reportAgainst *No report
First TrustSplit or no voteForFor
Russell InvestmentsForAgainst *For
Victory CapitalForForFor
Brighthouse FundsForForFor
Columbia ThreadneedleSplit or no voteForFor
BNY MellonForAgainst *For
PrincipalSplit or no voteForFor
Capital Group and American FundsForForFor
Pacific Life fundsForForFor
Global XForAgainst *For
Federated HermesForForFor
AllianceBernsteinSplit or no voteForFor
Hartford FundsForForFor
AllspringSplit or no voteForFor
Harbor FundsSplit or no voteForFor
Janus HendersonNo reportForNo report
Natixis and Loomis SaylesNo reportForNo report
Lord AbbettForForFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the NewAmsterdam Pharma Company N.V. meeting?

268 Form N-PX filers reported votes at the meeting of 2 Jun 2026. On say-on-pay, 57 of 248 voted against management (23.0%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by NewAmsterdam Pharma Company N.V. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for NewAmsterdam Pharma Company N.V.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing NewAmsterdam Pharma Company N.V. with a meeting date within three days of 2 Jun 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.